Atrium Therapeutics Inc (RNA)

EBITDA Margin

-741.51%

Quarterly · Period ending:

RNA logo

RNA EBITDA Margin

Latest reported-741.51%
RNA Quarterly EBITDA Margin (0.00% → -741.51%)
High-resolution chart · PNG

RNA ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-741.5113%
-83.9419%
-5,577.7648%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.